Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,870 | -54,410 | -70,539 | -55,783 | -66,246 |
| Depreciation Amortization | 3,317 | 2,602 | 6,695 | 6,030 | 4,834 |
| Accounts receivable | -3,073 | 7,352 | -5,353 | 6,175 | -6,815 |
| Other Working Capital | -5,341 | 31,977 | -1,730 | -4,413 | -11,124 |
| Other Operating Activity | 6,587 | 2,660 | 37,948 | 2,532 | 19,141 |
| Operating Cash Flow | $-6,380 | $-9,819 | $-32,979 | $-45,459 | $-60,210 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -995 | -1,024 | -913 | -517 | -663 |
| Purchase Sale Intangibles | 0 | -1,500 | 0 | N/A | N/A |
| Other Investing Activity | 0 | -1,500 | 0 | 0 | 0 |
| Investing Cash Flow | $-995 | $-2,524 | $-913 | $-517 | $-663 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 31,144 | N/A | N/A | N/A | 70,000 |
| Debt Repayment | -53,631 | -2,025 | 0 | -24,750 | -52,944 |
| Common Stock Issued | 17,259 | 13,620 | 30,123 | 6,215 | 39,317 |
| Other Financing Activity | 9,202 | -3 | -14 | 46,992 | -6,773 |
| Financing Cash Flow | $3,974 | $11,592 | $30,109 | $28,457 | $49,600 |
| Beginning Cash Position | 27,273 | 28,024 | 31,807 | 49,326 | 60,599 |
| End Cash Position | 23,872 | 27,273 | 28,024 | 31,807 | 49,326 |
| Net Cash Flow | $-3,401 | $-751 | $-3,783 | $-17,519 | $-11,273 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,380 | -9,819 | -32,979 | -45,459 | -60,210 |
| Capital Expenditure | -995 | -1,024 | -913 | -517 | -663 |
| Free Cash Flow | -7,375 | -10,843 | -33,892 | -45,976 | -60,873 |